Literature DB >> 17060341

The N-terminal domain of the Aurora-A Phe-31 variant encodes an E3 ubiquitin ligase and mediates ubiquitination of IkappaBalpha.

Paraskevi Briassouli1, Florence Chan, Spiros Linardopoulos.   

Abstract

Aurora-A is an important regulator of mitosis and is frequently amplified in human cancer. Ectopic expression of Aurora-A in mammalian cells induces centrosome amplification, genomic instability and transformation. A common genetic variant in Aurora-A (F31I) is preferentially amplified and is associated with the occurrence and the status of colon, oesophageal and breast cancers. Here we demonstrate that the N-terminal domain of Aurora-A Phe-31 variant exhibits an intrinsic ubiquitin ligase activity. Mutation of cysteines 8, 33 and 49 of Aurora-A abolishes the ubiquitin ligase activity of the protein. Aurora-A in a complex with UBE2N/MMS2 catalyses polyubiquitination of IkappaBalpha in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060341     DOI: 10.1093/hmg/ddl410

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  3 in total

Review 1.  Aurora kinase inhibitors as anticancer molecules.

Authors:  Hiroshi Katayama; Subrata Sen
Journal:  Biochim Biophys Acta       Date:  2010-09-20

2.  A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types.

Authors:  Rama K R Mettu; Ying-Wooi Wan; Jens K Habermann; Thomas Ried; Nancy Lan Guo
Journal:  Int J Biol Markers       Date:  2010 Oct-Dec       Impact factor: 2.659

3.  A small-molecule inhibitor targeting the AURKC-IκBα interaction decreases transformed growth of MDA-MB-231 breast cancer cells.

Authors:  Eun Hee Han; Jin-Young Min; Shin-Ae Yoo; Sung-Joon Park; Yun-Jeong Choe; Hee Sub Yun; Zee-Won Lee; Sun Woo Jin; Hyung Gyun Kim; Hye Gwang Jeong; Hyun Kyoung Kim; Nam Doo Kim; Young-Ho Chung
Journal:  Oncotarget       Date:  2017-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.